Presentation is loading. Please wait.

Presentation is loading. Please wait.

Supplemental Table 1 Source and authentication of cell lines.

Published byMeagan Fitzgerald Modified over 8 years ago

Similar presentations

Presentation on theme: "Supplemental Table 1 Source and authentication of cell lines."— Presentation transcript:

1 Supplemental Table 1 Source and authentication of cell lines

2 Supplemental Table 2 Primers used for quantitative real-time PCR Sequence Sequence 5’ to 3’ Name ForwardReverse LUCCCGCGTACGTGATGTTCACCGAGGATGGAACCGCTGGAGA CLUGAGCAGCTGAACGAGCAGCTTCGCCTTGCGTGAGGT

3 Supplemental Figure S1 PC-3M-luc 4x10 4 2x10 4 1x10 4 5x10 3 2.5x10 3 1.13x10 3 Mean Photons / Second Cell number

4 Supplemental Figure S2 -D8D0D8 Mean Photons / Second A B Mean tumor volume (mm 3 ) Mean Photons / Second Mean tumor volume (mm 3 ) x10 8 Photons/Second/cm 2 /sr 2.5 1.5 0.5

5 C D LNP GFP-siRNA 5mg/kg LNP LUC-siRNA 1 mg/Kg LUC B-Actin LNP LUC-siRNA 2.5 mg/Kg LNP LUC-siRNA 5 mg/Kg E LUC mRNA expression (% of control) Relative Increase (%) * ** Mean mice body weight (g) Supplemental Figure S3 AB Mean tumor volume (mm 3 )

6 Supplemental Figure S4 ** Cell growth (% of control) ENZ μ mol/L ** LNCaP

Download ppt "Supplemental Table 1 Source and authentication of cell lines."

Similar presentations

Supplemental Figure 1 a % pulldown from input LNCaP/scrambled-siRNA Figure 1 A, ChIP analysis of AR and PHB binding to the PSA promoter in the LNCaP/scrambled-siRNA.

Supplemental Figure 1 a % pulldown from input LNCaP/scrambled-siRNA Figure 1 A, ChIP analysis of AR and PHB binding to the PSA promoter in the LNCaP/scrambled-siRNA.
Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.

Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.
Counts TLR3-PE 100 80 60 40 20 0 Counts TLR8-PE 100 80 60 40 20 0 Counts TLR9-PE 100 80 60 40 20 0 C AB Supplemental Figure 1.

Counts TLR3-PE Counts TLR8-PE Counts TLR9-PE C AB Supplemental Figure 1.
Supplemental Figure 1 A No. at risk T3 530 483 304 185 50 T2 559 545 373 228 76 T1 540 532 375 208 64.

Supplemental Figure 1 A No. at risk T T T
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
Clancy-Thompson et al., Supplemental Figure 1 A B C Supplemental Figure 1: Mice were given intravenous B16 injection on day 0. A) After bearing tumors.

Clancy-Thompson et al., Supplemental Figure 1 A B C Supplemental Figure 1: Mice were given intravenous B16 injection on day 0. A) After bearing tumors.
Herceptin + 17-AAG Combination BT-474 Tumors

Herceptin + 17-AAG Combination BT-474 Tumors
Figure 1 A -SN50-C8-S-A2-G7 B C HCT116-sHCT116-SN6 NTSN38NTSN38 HCT116-s pp38 tubulin NT 0.1µM 1µM 5µM 10µM pp38 tubulin HCT116-SN6 [SN38] 24H pp38 NT.

Figure 1 A -SN50-C8-S-A2-G7 B C HCT116-sHCT116-SN6 NTSN38NTSN38 HCT116-s pp38 tubulin NT 0.1µM 1µM 5µM 10µM pp38 tubulin HCT116-SN6 [SN38] 24H pp38 NT.
Supplementary Figures&Legends. Figure1. Subcutaneous xenograft tumor models of the control group.

Supplementary Figures&Legends. Figure1. Subcutaneous xenograft tumor models of the control group.
Figure S1. The coding sequence alignment among OsAHPs and OsPHPs, and the relative expression of OsAHPs and OsPHPs in OsAHPs-RNAi and wild-type rice seedlings.

Figure S1. The coding sequence alignment among OsAHPs and OsPHPs, and the relative expression of OsAHPs and OsPHPs in OsAHPs-RNAi and wild-type rice seedlings.
Supplementary Figure 1. Compararison of the expression of the genes within the 10q23 locus using either Troglitazone or Rosiglitazone as the PPAR  agonist.

Supplementary Figure 1. Compararison of the expression of the genes within the 10q23 locus using either Troglitazone or Rosiglitazone as the PPAR  agonist.
Supplemental Figure 1. Remicade treatment did not affect body weight and muscle weight in mdx mice. Mdx mice were treated with Remicade (10 mg/ml) starting.

Supplemental Figure 1. Remicade treatment did not affect body weight and muscle weight in mdx mice. Mdx mice were treated with Remicade (10 mg/ml) starting.
Fig.S1. Effects of various inhibitors on LPS-induced TNFα mRNA expression in RAW264.7 cells. The same experimental procedures were performed as described.

Fig.S1. Effects of various inhibitors on LPS-induced TNFα mRNA expression in RAW264.7 cells. The same experimental procedures were performed as described.
Con WTTM Supplementary Figure 1 Supplementary Figure 1. Tumor histopathology of the lungs. (a) Histological examination of lungs of 52-week-old K- ras.

Con WTTM Supplementary Figure 1 Supplementary Figure 1. Tumor histopathology of the lungs. (a) Histological examination of lungs of 52-week-old K- ras.
Supplementary Figure 1 Rluc8 β- lactamase araC Ori from pMB1 pBAD-RLuc8 4930 bp P BAD ClyA β- lactamase araC Ori from pMB1 pBAD-ClyA 4883 bp P BAD A B.

Supplementary Figure 1 Rluc8 β- lactamase araC Ori from pMB1 pBAD-RLuc bp P BAD ClyA β- lactamase araC Ori from pMB1 pBAD-ClyA 4883 bp P BAD A B.
Supplemental Figure 1. Loss of Stat3 expression did not change IFN-induced chemokine levels in tumors. (A) Realtime PCR analysis of mRNA expression levels.

Supplemental Figure 1. Loss of Stat3 expression did not change IFN-induced chemokine levels in tumors. (A) Realtime PCR analysis of mRNA expression levels.
Supplementary Fig. 1. RT-PCR showed that tumor tissues have elevated Mst1 mRNA levels in most of the HCC patients tested. GAPDH RT-PCR products were shown.

Supplementary Fig. 1. RT-PCR showed that tumor tissues have elevated Mst1 mRNA levels in most of the HCC patients tested. GAPDH RT-PCR products were shown.
Fig. S1 Beclin1, ATG3 and LC3B mRNA -real-time quantitative PCR HCT-116 HT-29.

Fig. S1 Beclin1, ATG3 and LC3B mRNA -real-time quantitative PCR HCT-116 HT-29.
The reading is 7.38 mm. The reading is 7.72 mm.

The reading is 7.38 mm. The reading is 7.72 mm.
Molecular Therapy - Nucleic Acids

Molecular Therapy - Nucleic Acids

Similar presentations

Ads by Google